STOCK TITAN
  1. Home
  2. Sec-filings
  3. TNMG
  4. [6-K] TNL Mediagene Current Report (Foreign Issuer)

Nasdaq panel lets TNL Mediagene (NASDAQ: TNMG) stay under conditions

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

TNL Mediagene (TNMG) reports that the Nasdaq Hearings Panel has granted its request for continued listing on The Nasdaq Capital Market, subject to meeting specified conditions during an exception period. The decision follows an August 4, 2026 hearing where the company presented a plan to regain compliance with Nasdaq’s Bid Price Rule and Equity Rule.

The company’s ordinary shares will continue trading under symbol TNMG while it works to regain and maintain compliance, and it must promptly notify Nasdaq of any significant events affecting its status. The Panel may reconsider the exception if circumstances change, and TNL Mediagene cautions that there is no assurance it will satisfy the conditions; failure would result in delisting of its securities from Nasdaq.

Positive

  • Nasdaq grants conditional continued listing for TNMG on The Nasdaq Capital Market, allowing the company to remain traded while it pursues its plan to regain compliance with the Bid Price Rule and Equity Rule.
  • Exception period provides time for TNL Mediagene to execute its compliance plan, with its ordinary shares continuing to trade under the symbol TNMG during this period.

Negative

  • Risk of Nasdaq delisting remains because TNL Mediagene states there is no assurance it will meet the Panel’s conditions; failure to regain compliance with listing requirements would result in delisting of its securities.
  • Prior Nasdaq determination to delist was issued on June 22, 2026 due to non-compliance with the Bid Price Rule and Equity Rule, underscoring ongoing listing-compliance challenges.
Panel decision date August 23, 2026 Date TNL Mediagene received the written decision granting conditional continued listing
Hearing date August 4, 2026 Date of Nasdaq Hearings Panel session where the company presented its compliance plan
Nasdaq determination letter date June 22, 2026 Date Nasdaq staff determined to delist the company’s securities
Hearing request date June 29, 2026 Date TNL Mediagene requested a hearing before the Nasdaq Hearings Panel
Hearing scheduling notice date July 1, 2026 Date Nasdaq notified the company that its hearing request was granted and scheduled
Bid Price Rule regulatory
"plan to regain compliance with the Bid Price Rule and the Equity Rule"
Equity Rule regulatory
"plan to regain compliance with the Bid Price Rule and the Equity Rule"
Nasdaq Hearings Panel regulatory
"received a written decision from the Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
continued listing regulatory
"granting the Company’s request for continued listing on The Nasdaq Capital Market"
When a stock receives a "continued listing," it means the exchange has decided the company’s shares will remain tradable on that market after a review or challenge, often because the company met certain requirements or corrective steps. For investors this matters because continued listing preserves liquidity and access to buy or sell the stock—think of it as a store passing an inspection so customers can keep shopping rather than being forced to close.
exception period regulatory
"significant events occurring during the exception period that may affect the Company’s compliance"

FAQ

What did Nasdaq decide regarding TNL Mediagene (TNMG)’s listing status?
Nasdaq’s Hearings Panel granted TNL Mediagene’s request for continued listing on The Nasdaq Capital Market, subject to the company satisfying certain conditions during an exception period, following a hearing held on August 4, 2026.

Why was TNL Mediagene (TNMG) at risk of delisting from Nasdaq?
TNL Mediagene received a determination letter on June 22, 2026 stating Nasdaq staff’s decision to delist its securities due to failure to regain compliance with the Bid Price Rule and previously notified non-compliance with the Equity Rule.

Will TNL Mediagene (TNMG) shares continue trading on Nasdaq?
Yes. The company states its ordinary shares will continue to be listed and traded on The Nasdaq Capital Market under the symbol TNMG during the exception period, subject to satisfying the conditions set forth in the Panel’s decision.

What are the key conditions attached to TNL Mediagene (TNMG)’s continued listing?
The company must satisfy conditions set by the Nasdaq Hearings Panel, including an obligation to promptly notify Nasdaq of significant events affecting compliance. The decision is tied to the company’s plan to regain compliance with the Bid Price Rule and Equity Rule.

Is there any guarantee that TNL Mediagene (TNMG) will remain listed on Nasdaq?
No. TNL Mediagene states there can be no assurance it will satisfy the Panel’s conditions or regain compliance. Failure to do so would result in the delisting of the company’s securities from Nasdaq.

When did TNL Mediagene (TNMG) present its compliance plan to Nasdaq?
TNL Mediagene presented its plan to regain compliance with the Bid Price Rule and Equity Rule at a hearing before the Nasdaq Hearings Panel held on August 4, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16

OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2026

 

Commission File Number 001-42424

 

TNL Mediagene

 

23-2 Maruyamacho   4F., No. 88, Yanchang Rd.
Shibuya-ku, Tokyo 150-0044   Xinyi District
Japan   Taipei City 110
+81-(0)3-5784-6742   Taiwan
    +886-2-6638-5108

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒        Form 40-F ☐

 

 

 

 

 

 

Explanatory Note

 

On August 23, 2026, TNL Mediagene (the “Company”) received a written decision from the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for continued listing on The Nasdaq Capital Market, subject to the Company’s satisfaction of certain conditions. Those conditions include the following:

 

-On or before September 21, 2026, the Company must demonstrate compliance with the Listing Rule 5550(a)(2) (the “Bid Price Rule”); and
  
-On or before October 30, 2026, the Company must demonstrate compliance with the Listing Rule 5550(b)(1) (the “Equity Rule”).

 

The Panel’s decision also requires the Company to provide prompt notification of any significant events occurring during the exception period that may affect the Company’s compliance with Nasdaq requirements, including any event that may call into question the Company’s ability to meet the terms of the exception granted. The Panel has reserved the right to reconsider the terms of the exception based on any event, condition or circumstance that exists or develops that would, in the opinion of the Panel, make continued listing of the Company’s securities on Nasdaq inadvisable or unwarranted. The foregoing summarizes certain terms of the Panel’s decision and does not describe all of the terms and conditions of the decision.

 

The decision was made by the Panel following a hearing held on August 4, 2026, during which the Company presented its plan to regain compliance with the Bid Price Rule and the Equity Rule. The Company’s ordinary shares will continue to be listed and traded on Nasdaq under the symbol “TNMG” during the exception period, subject to the Company’s satisfaction of the conditions set forth in the Panel’s decision. Any compliance submission by the Company will be subject to review by the Panel. There can be no assurance that the Company will satisfy the conditions of the Panel’s decision or otherwise regain compliance with the applicable listing requirements, and a failure to do so would result in the delisting of the Company’s securities from Nasdaq.

 

On June 22, 2026, the Company received a determination letter (the “Determination Letter”) from the staff of the Listing Qualifications Department of Nasdaq notifying the Company of the staff’s determination to delist the Company’s securities from The Nasdaq Capital Market as a result of the Company’s failure to regain compliance with the Bid Price Rule and the Company’s previously notified non-compliance with the Equity Rule, as described in the Company’s Report of Foreign Private Issuer on Form 6-K furnished to the U.S. Securities and Exchange Commission on June 26, 2026. On June 29, 2026, the Company requested a hearing before the Panel. On July 1, 2026, Nasdaq notified the Company that the hearing request had been granted and scheduled the hearing for August 4, 2026.

 

A copy of the press release regarding the grant of the Company’s request for continued listing subject to these conditions is furnished herewith as Exhibit 99.1 to this Report on Form 6-K and is incorporated by reference herein.

 

Exhibit No.   Description of Exhibits
99.1   Press Release by TNL Mediagene dated August 25, 2026

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  TNL Mediagene
     
Date: August 25, 2026 By: /s/ Motoko Imada
    Name:  Motoko Imada
    Title: Chief Executive Officer

 

2

 

 

Exhibit 99.1

 

TNL Mediagene Granted Continued Nasdaq Listing Subject to Conditions 

 

 

-Among the conditions, the Company must demonstrate compliance with the minimum bid price requirement by September 21, 2026 and the stockholders’ equity requirement by October 30, 2026

 

TOKYO, August 25, 2026 -- TNL Mediagene (Nasdaq: TNMG) (the “Company”), a technology and digital media company providing AI-driven advertising, marketing technology, content commerce and data analytics solutions, and operating multi-language digital media brands across Asia, today announced that on August 23, 2026, the Company received a written decision from the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for continued listing on The Nasdaq Capital Market, subject to the Company’s satisfaction of certain conditions. Those conditions include the following:

 

●On or before September 21, 2026, the Company must demonstrate compliance with the Listing Rule 5550(a)(2) (the “Bid Price Rule”); and

 

●On or before October 30, 2026, the Company must demonstrate compliance with the Listing Rule 5550(b)(1) (the “Equity Rule”).

 

The Panel’s decision also requires the Company to provide prompt notification of any significant events occurring during the exception period that may affect the Company’s compliance with Nasdaq requirements, including any event that may call into question the Company’s ability to meet the terms of the exception granted. The Panel has reserved the right to reconsider the terms of the exception based on any event, condition or circumstance that exists or develops that would, in the opinion of the Panel, make continued listing of the Company’s securities on Nasdaq inadvisable or unwarranted. The foregoing summarizes certain terms of the Panel’s decision and does not describe all of the terms and conditions of the decision.

 

The Panel’s decision follows a hearing held on August 4, 2026, at which the Company presented its plan to regain compliance with the Bid Price Rule and the Equity Rule. The Company’s ordinary shares will continue to be listed and traded on Nasdaq under the symbol “TNMG” during the exception period, subject to the Company’s satisfaction of the conditions set forth in the Panel’s decision. Any compliance submission by the Company will be subject to review by the Panel. There can be no assurance that the Company will satisfy the conditions of the Panel’s decision or otherwise regain compliance with the applicable listing requirements, and a failure to do so would result in the delisting of the Company’s securities from Nasdaq.

 

On June 22, 2026, the Company received a determination letter (the “Determination Letter”) from the staff of the Listing Qualifications Department of Nasdaq notifying the Company of the staff’s determination to delist the Company’s securities from The Nasdaq Capital Market as a result of the Company’s failure to regain compliance with the Bid Price Rule and the Company’s previously notified non-compliance with the Equity Rule, as described in the Company’s press release dated June 26, 2026. On June 29, 2026, the Company requested a hearing before the Panel. On July 1, 2026, Nasdaq notified the Company that the hearing request had been granted and scheduled the hearing for August 4, 2026.

 

 

About TNL Mediagene

 

Headquartered in Tokyo, TNL Mediagene (Nasdaq: TNMG) is a technology and digital media company providing AI-driven advertising, marketing technology, content commerce and data analytics solutions, and operating multi-language digital media brands across Asia. Formed in May 2023 through the merger of Japan’s Mediagene Inc. and Taiwan’s The News Lens Co., Ltd., the Company combines advertising and marketing technology platforms with a portfolio of established digital media brands to deliver integrated solutions for the evolving digital landscape.

 

The Company’s technology offerings include AI-driven advertising, marketing and digital studio services, content commerce, and advanced data analytics capabilities. These solutions are supported by the Company’s well-established multi-language digital media brands in Japanese, Chinese, and English, spanning business, technology, lifestyle, and culture, which provide audience engagement and first-party data.

 

Known for its appeal to younger audiences, and high-quality content, TNL Mediagene has approximately 480 employees with offices in Japan and Taiwan.

 

https://www.tnlmediagene.com/

 

For further information, please contact:

 

Media: PR@tnlmediagene.com

 

Investors: IR@tnlmediagene.com

 

Cautionary Statement Regarding Forward-Looking Statements 

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene’s future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “aim,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements in this communication include, but are not limited to, statements regarding the Company’s ability to satisfy the conditions of the Panel’s decision and to regain and maintain compliance with Nasdaq’s continued listing requirements, and the potential delisting of the Company’s securities from Nasdaq. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene’s filings with the Securities and Exchange Commission, including the risks and uncertainties set forth under the heading “Risk Factors” in TNL Mediagene’s FY2025 Annual Report on Form 20-F filed on April 30, 2026, as may be supplemented or amended by the TNL Mediagene’s Reports of a Foreign Private Issuer on Form 6-K. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.

 

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document

Press Releases